Eric Drape - 04 Mar 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Reporting relationship: Executive VP Global Operations
Issuer ticker: TEVA
Reported as of: 04 Mar 2022
Net transaction value: -$259,019
SEC form: 4
Accepted by SEC: 08 Mar 2022, 15:05:35 UTC
Prior SEC filing: 02 Mar 2022
Next SEC filing: 09 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Dov Bergwerk as attorney-in-fact for Eric Drape

Key filing fact

Eric Drape filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 08 Mar 2022.

Key facts

This page summarizes Eric Drape's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
10 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 08 Mar 2022, 15:05.

Change

Previous filing in this sequence was filed on 02 Mar 2022.
Current net transaction value: -$259,019.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TEVA transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +32,518
Change %: +71%
Price
Shares after: 78,348
Date: 04 Mar 2022
Ownership: Direct
Footnotes: F1, F2

TEVA transaction

Ordinary Shares

Sale

Transaction value: $128,377
Shares: -17,157
Change %: -22%
Price: $7.48
Shares after: 61,191
Date: 04 Mar 2022
Ownership: Direct
Footnotes: F1, F3, F4, F5

TEVA transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +11,940
Change %: +20%
Price
Shares after: 73,131
Date: 04 Mar 2022
Ownership: Direct
Footnotes: F1, F2

TEVA transaction

Ordinary Shares

Sale

Transaction value: $47,147
Shares: -6,301
Change %: -8.6%
Price: $7.48
Shares after: 66,830
Date: 04 Mar 2022
Ownership: Direct
Footnotes: F1, F3, F4, F5

TEVA transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +22,576
Change %: +34%
Price
Shares after: 89,406
Date: 05 Mar 2022
Ownership: Direct
Footnotes: F1, F2

TEVA transaction

Ordinary Shares

Sale

Transaction value: $83,494
Shares: -11,334
Change %: -13%
Price: $7.37
Shares after: 78,072
Date: 07 Mar 2022
Ownership: Direct
Footnotes: F1, F3, F4, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TEVA transaction Derivative

Restricted Share Units

Options Exercise

Transaction value: $0
Shares: -32,518
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Mar 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 32,518
Exercise price
Footnotes: F1, F2, F7

TEVA transaction Derivative

Restricted Share Units

Options Exercise

Transaction value: $0
Shares: -11,940
Change %: -50%
Price: $0.000000
Shares after: 11,940
Date: 04 Mar 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 11,940
Exercise price
Footnotes: F1, F2, F8

TEVA transaction Derivative

Restricted Share Units

Award

Transaction value: $0
Shares: +134,048
Change %
Price: $0.000000
Shares after: 134,048
Date: 04 Mar 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 134,048
Exercise price
Footnotes: F1, F2, F9

TEVA transaction Derivative

Restricted Share Units

Options Exercise

Transaction value: $0
Shares: -22,576
Change %: -25%
Price: $0.000000
Shares after: 67,728
Date: 05 Mar 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 22,576
Exercise price
Footnotes: F1, F2, F10

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

Footnote F3

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Footnote F4

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.49, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F7

Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022.

Footnote F8

Restricted share units were granted on March 4, 2019, with 11,940 having vested on each of March 4, 2021 and March 4, 2022, and 11,940 vesting on March 4, 2023.

Footnote F9

Restricted share units were granted on March 4, 2022, with 33,512 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026.

Footnote F10

Restricted share units were granted on March 5, 2021, with 22,576 having vested on March 5, 2022 and 22,576 vesting on each of March 5, 2023, March 5, 2024 and March 5, 2025.